Log on/register
BioMed Central home | Journals A-Z | Feedback | Support | My details
 

This article is part of the supplement: AIDS Vaccine 2009 .

Open AccessOral presentation

OA021-01. Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccines

B Jacobs1, K Kibler1, S Wong1, T Huynh1, S Holechek1, K Denzler1, W Arndt1, M Parrington2, J Tartaglia2 and G Pantaleo3

The Biodesign Institute, CIDV, Arizona State University, Tempe, AZ, USA

Sanofi-Pasteur, Toronto, Canada

CHUV, Lausanne, Switzerland

corresponding author email

from AIDS Vaccine 2009
Paris, France. 19–22 October 2009

Retrovirology 2009, 6(Suppl 3):O13doi:10.1186/1742-4690-6-S3-O13

Published: 22 October 2009

First paragraph (this article has no abstract)

Poxvirus viruses have been utilized for many years as vaccine vectors. Recent years have seen an increase in efforts to identify safer pox vectors to express heterologous antigens, in this case HIV antigens.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.